Leora Horn — ASN Events

Leora Horn — ASN Events

Ngan Huynh

Bristol-Myers Squibb, VIC, Australia

Presentations this author is a contributor to:

Phase 3, randomized trial (CheckMate 017) of nivolumab (Nivo) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) (#214)

Nivolumab (Nivo) monotherapy or in combination with ipilimumab (Ipi) for treatment of recurrent small cell lung cancer (SCLC) (#187)

Longer-term follow-up of a phase 2 study (CheckMate 063) of nivolumab in patients with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC) (#200)